A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)

Hôpital de la Timone, Marseille

Azienda Socio-Sanitaria Territoriale Santi Paolo e Carlo - Ospedale San Paolo Polo Universitario, Milan

Hospital Universitario La Paz, Madrid

Medizinische Hochschule Hannover, Hanover

Complejo Hospitalario de Navarra, Pamplona

Hôpital Saint-André, Bordeaux

Mount Sinai Comprehensive Cancer Center, Miami Beach

Institut Régional du Cancer de Montpellier, Montpellier

Hospital Universitario Virgen del Rocío, Seville

Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy

Centre de Lutte contre le Cancer - Centre Oscar Lambret, Lille

Siteman Cancer Center - North County, Florissant

Washington University School of Medicine Center for Advanced Medicine, St Louis

Siteman Cancer Center - West County, Creve Coeur

Siteman Cancer Center - St. Peters, City of Saint Peters

Ramsay Health Clinic Belharra, Bayonne

Centre Léon Bérard, Lyon

Centre Hospitalier Universitaire Amiens-Picardie - Site Sud, Amiens

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma

Centrum Onkologii Im. Prof. F. Łukaszczyka w Bydgoszczy, Bydgoszcz

Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie-Państwowy Instytut Badawczy O. w Gliwicach, Gliwice

Hospital Clínic de Barcelona, Barcelona

The Royal Marsden Hospital - London, London

The Royal Marsden Hospital Head and Neck Unit, Sutton